Our new in vivo evidence suggests bone metastatic breast cancer cells induce a non-normal osteoblast state of osteopontin (OPN) high, alpha-smooth muscle actin (aSMA) low, and IL-6 low (Figs. 1, 2, 5, and 12b). This evidence concerns the gene IL6 and breast cancer.